Quantcast
Last updated on April 16, 2014 at 21:24 EDT

Latest Leica Biosystems Stories

2013-11-12 04:22:36

BUFFALO GROVE, Illinois, November 12, 2013 /PRNewswire/ -- Leica Biosystems announces the launch of the fourth Novocastra(TM) HD menu, focused on hematopathology. Previously launched were the Novocastra HD menus for breast, head & neck and dermatopathology. The new Novocastra HD menu for hematopathology is now available for sale in the USA, Canada and the EU. Availability in other regions will follow. The hematopathology menu includes 50 new products. Full details...

2013-07-08 12:28:52

NEWCASTLE-UPON-TYNE, England and AMSTERDAM, July 8, 2013 /PRNewswire/ -- Leica Biosystems announced that it has acquired Kreatech Diagnostics, a privately-held provider of DNA fluorescent in-situ hybridization (FISH) probes and target labeling reagents for microarrays. "We are very pleased with the acquisition of Kreatech, its extensive portfolio and development expertise. This will allow Leica Biosystems to better serve our cytogenetics and anatomic pathology...

2013-03-12 04:21:19

NEWCASTLE-UPON-TYNE, England, March 12, 2013 /PRNewswire/ -- - Leica Biosystems and Synthon Biopharmaceuticals announce partnership to develop a companion diagnostic test for solid tumors - Leica Biosystems will develop a fully automated tissue-based companion diagnostic test to run on the BOND(TM)automated advanced staining systems - Synthon strengthens its innovative drug pipeline with the development of a companion...

2013-03-06 08:27:45

VISTA, Calif., March 6, 2013 /PRNewswire/ -- Leica Biosystems, which through its acquisition of Aperio became the leading provider of digital pathology systems, announced today that Chinese physicians have access to U.S. healthcare organizations for real-time, expert review of pathology cases through the first scalable, secure medical cloud network through its strategic collaboration with Dell Healthcare and Life Sciences. The U.S. institutions providing pathology services include: The Johns...

2012-10-01 02:31:12

NEWCASTLE UPON TYNE, England, October 1, 2012 /PRNewswire/ -- Leica Biosystems [http://www.leicabiosystems.com/products/total-histology/novocastra-reagents/novocastra-hd ] announces the availability of the Novocastra(TM) HD menu for breast pathology, the first portfolio of independently qualified* antibodies from the new Novocastra HD range. Together with the FDA approval of the Leica BOND Oracle HER2 IHC System on April 18, 2012, this new menu affirms Leica Biosystems'...

2012-08-21 10:24:22

NUSSLOCH, Germany and VISTA, Calif., Aug. 21, 2012 /PRNewswire/ -- Leica Biosystems announced that an affiliate has entered into a definitive agreement to acquire Aperio, a leading provider of ePathology solutions. Aperio will be integrated into Leica Biosystems, a leader in anatomical pathology solutions. Together, the two businesses will leverage each other's strengths to grow and expand digital pathology into the global Life Science and Healthcare markets. The integrated business will...

2012-04-25 02:30:59

NEWCASTLE UPON TYNE, England, April 25, 2012 /PRNewswire/ -- Leica Biosystems, a division of Leica Microsystems, announced that it has received Pre-Market Approval from the U.S. Food and Drug Administration for the Leica Bond Oracle HER2 IHC System (Product Code TA9147) with the Leica BOND-MAX, establishing their commitment to developing quality companion diagnostic products. The Leica Bond Oracle HER2 IHC System is a complete solution of ready-to-use reagents, HER2 control...

2011-08-08 04:00:00

BEIJING and WETZLAR, Germany, Aug. 8, 2011 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (CMED) (Nasdaq: CMED), a leading China-based advanced in-vitro diagnostic ("IVD") company, and Leica Biosystems, a division of Leica Microsystems, a world leader in microscopes and scientific instruments, today announced that they have established a sales, research and development collaboration to co-develop and market automated FISH kits to be used on the Leica BOND system. CMED...